A Randomized Phase 2 Study Exploring the Role of Bevacizumab and a Chemotherapy-Free Approach in HER2-Positive Metastatic Breast Cancer: The HAT Study (BOOG 2008-2003), a Dutch Breast Cancer Research Group Trial

Jan Drooger, H van Tinteren, SM de Groot, AJ ten Tije, H de Graaf, JEA Portielje, Agnes Jager, A Honkoop, SC Linn, JR Kroep, FLG Erdkamp, P Hamberg, A L T Imholz, Q C van Rossum-Schornagel, JB Heijns, AE van Leeuwen-Stok, Stefan Sleijfer

Research output: Contribution to journalArticleAcademicpeer-review

8 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)2961-2970
Number of pages10
Issue number19
Publication statusPublished - 2016

Research programs

  • EMC MM-03-86-01
  • EMC MM-03-86-08

Cite this